Comparable stake leader
JPMORGAN CHASE & CO
SEC ownership of Natera, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001604821.
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
50/50
Latest evidence
27 Jul 2026
- Public ticker
- NTRA on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
JPMORGAN CHASE & CO
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
JPMORGAN CHASE & CO
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
27 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001604821
- Issuer location
- Austin, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Natera, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JPMORGAN CHASE & CO
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
50/50
Latest evidence
27 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.1%
13D/G row: JPMORGAN CHASE & CO
Showing 1-8 of 50 holder rows.
Quick read
JPMORGAN CHASE & CO leads the comparable SEC ownership view at 9.1%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JPMORGAN CHASE & CO's linked filing trail.
Comparable ownership
Top 5
JPMORGAN CHASE & CO
9.1%
PRICE T ROWE ASSOCIATES INC /MD/
7.8%
BlackRock, Inc.
5.6%
VANGUARD CAPITAL MANAGEMENT LLC
5.1%
Matthew Rabinowitz
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13D/G
13F
Company
|
9.1%
|
$2,938,225,868
12,825,640 shares
|
+$511,187,761 | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
7.8%
|
$2,547,582,806
10,872,702 shares
|
-$309,081,133 | 31 Dec 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.6%
from 13D/G
|
$2,135,360,953
10,677,338 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.1%
|
$1,441,115,741
7,205,939 shares
|
$0 | 31 Mar 2026 |
| Matthew Rabinowitz |
3/4/5
EXECUTIVE CHAIRMAN, Director
|
1.6%
|
$593,995,422
2,280,125 shares
|
-$81,881,476 | 27 Jul 2026 |
| James Healy |
3/4/5
Director
|
1.1%
|
$225,766,720
1,596,540 shares
|
— | 25 Apr 2025 |
| Roelof Botha |
3/4/5
Director
|
0.76%
|
$216,145,792
1,080,783 shares
|
-$34,893,028 | 26 Jun 2026 |
| Jonathan Sheena |
3/4/5
Director, CO-FOUNDER
|
0.2%
|
$72,220,316
281,787 shares
|
-$18,217,734 | 27 Jul 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$320,642,777.
Buys
$0
Insiders: 0
Sells
$320,642,777
Insiders: 12
Net
-$320,642,777
Shares: -1,496,148
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 1,496,148
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 351,228 | $0 | $80,107,044 | -$80,107,044 |
| 3-6 | 0 | 271,436 | $0 | $52,658,464 | -$52,658,464 |
| 6-9 | 0 | 533,392 | $0 | $123,576,199 | -$123,576,199 |
| 9-12 | 0 | 340,092 | $0 | $64,301,070 | -$64,301,070 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to Natera, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Matthew Rabinowitz
Net 12M change
-$320,642,777
Latest report
27 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN, Director | $593,995,422 | -$81,881,476 | -12% | Mixed | 27 Jul 2026 |
| James Healy | Director | $225,766,720 | Mixed | 25 Apr 2025 | ||
| Roelof Botha | Director | $216,145,792 | -$34,893,028 | -14% | Mixed | 26 Jun 2026 |
| Jonathan Sheena | Director, CO-FOUNDER | $72,220,316 | -$18,217,734 | -20% | Mixed | 27 Jul 2026 |
| John Fesko | President, Chief Bus. Officer | $46,766,502 | -$7,276,579 | -13% | Filing P/S | 27 Jul 2026 |
| Daniel Rabinowitz | Sec. And Chief Legal Officer | $43,662,316 | -$23,740,602 | -35% | Mixed | 27 Jul 2026 |
| Solomon Moshkevich | President, Clinicaldiagnostics | $33,646,302 | -$16,690,151 | -33% | Filing P/S | 27 Jul 2026 |
| Steven Leonard Chapman | CEO AND PRESIDENT, Director | $28,757,155 | -$93,433,337 | -76% | Mixed | 27 Jul 2026 |
| Michael Burkes Brophy | Chief Financial Officer | $13,964,740 | -$21,919,036 | -61% | Mixed | 27 Jul 2026 |
| Robert Alan Schueren | Chief Operating Officer | $9,082,035 | Mixed | 27 Jan 2023 | ||
| Roy D. Baynes | Director | $4,031,398 | -$2,809,689 | -41% | Mixed | 26 Jun 2026 |
| Gail Boxer Marcus | Director | $1,778,045 | -$2,413,571 | -58% | Mixed | 26 Jun 2026 |
| Monica Bertagnolli | Director | $1,403,929 | Mixed | 26 Jun 2026 | ||
| Rowan E. Chapman | Director | $1,281,485 | -$2,223,597 | -63% | Filing P/S | 15 Jul 2026 |
| Herm Rosenman | Director | $1,185,340 | -$15,143,977 | -93% | Mixed | 26 Jun 2026 |
| Brinkley Ruth Williams | Director | $1,094,945 | Mixed | 24 Apr 2026 | ||
| Todd C. Cozzens | Director | $1,038,936 | Mixed | 25 May 2022 | ||
| Eric H. Rubin | Director | $440,777 | Mixed | 26 Jun 2026 | ||
| Thomas J. Lynch Jr. | Director | $380,980 | Mixed | 26 Jun 2026 |
Recent insider transactions for Natera, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -3.43% | $464,595 | $249.38 | -1,863 | 52,432 | 29 Jul 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.08% | $48,527 | $254.07 | -191 | 245,723 | 28 Jul 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.59% | $254,833 | $254.07 | -1,003 | 170,407 | 28 Jul 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -0.9% | $305,901 | $254.07 | -1,204 | 132,429 | 28 Jul 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.5% | $236,540 | $254.07 | -931 | 184,069 | 28 Jul 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -3.36% | $909,572 | $254.07 | -3,580 | 102,973 | 28 Jul 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -4.27% | $614,336 | $253.96 | -2,419 | 54,295 | 28 Jul 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.12% | $75,021 | $260.49 | -288 | 245,914 | 27 Jul 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -0.08% | $447,523 | $260.49 | -1,718 | 2,276,125 | 27 Jul 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.51% | $230,274 | $260.49 | -884 | 171,410 | 27 Jul 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -0.75% | $263,096 | $260.49 | -1,010 | 133,633 | 27 Jul 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.42% | $203,704 | $260.49 | -782 | 185,000 | 27 Jul 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -2.01% | $570,475 | $260.49 | -2,190 | 106,553 | 27 Jul 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -1.36% | $203,704 | $260.49 | -782 | 56,714 | 27 Jul 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.99% | $205,420 | $273.89 | -750 | 18,032 | 15 Jul 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.99% | $205,405 | $273.87 | -750 | 18,032 | 15 Jul 2026 | By Caraluna 1 Trust |
| Rowan E. Chapman | NTRA | Common Stock | Sale | -2.81% | $37,101 | $274.82 | -135 | 4,663 | 15 Jul 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.26% | $836,898 | $265.68 | -3,150 | 246,202 | 13 Jul 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -20% | $280,000 | $280.00 | -1,000 | 4,000 | 06 Jul 2026 | By spouse |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -8.88% | $4,574,431 | $272.29 | -16,800 | 172,294 | 01 Jul 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -2.18% | $818,710 | $272.90 | -3,000 | 134,643 | 01 Jul 2026 | Direct |
| Eric H. Rubin | NTRA | Common Stock | Award | 3.52% | 75 | 2,204 | 26 Jun 2026 | Direct | ||
| Herm Rosenman | NTRA | Common Stock | Award | 39.5% | 1,677 | 5,927 | 26 Jun 2026 | Direct | ||
| Gail Boxer Marcus | NTRA | Common Stock | Award | 27% | 1,669 | 7,852 | 26 Jun 2026 | Direct | ||
| Thomas J. Lynch Jr. | NTRA | Common Stock | Award | 1,905 | 1,905 | 26 Jun 2026 | Direct | |||
| Rowan E. Chapman | NTRA | Common Stock | Award | 53.6% | 1,674 | 4,798 | 26 Jun 2026 | Direct | ||
| Roelof Botha | NTRA | Common Stock | Award | 58.4% | 1,691 | 4,585 | 26 Jun 2026 | Direct | ||
| Monica Bertagnolli | NTRA | Common Stock | Award | 30.6% | 1,646 | 7,020 | 26 Jun 2026 | Direct | ||
| Roy D. Baynes | NTRA | Common Stock | Award | 8.89% | 1,646 | 20,158 | 26 Jun 2026 | Direct | ||
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -15.1% | $8,455,355 | $251.65 | -33,600 | 189,094 | 24 Jun 2026 | Direct |
| Herm Rosenman | NTRA | Common Stock | Sale | -79.6% | $4,132,500 | $250.00 | -16,530 | 4,250 | 24 Jun 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.84% | $164,912 | $219.88 | -750 | 18,782 | 17 Jun 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.84% | $164,898 | $219.86 | -750 | 18,782 | 17 Jun 2026 | By Caraluna 1 Trust |
| Rowan E. Chapman | NTRA | Common Stock | Sale | -48.7% | $642,536 | $216.78 | -2,964 | 3,124 | 16 Jun 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.25% | $665,087 | $211.14 | -3,150 | 249,352 | 15 Jun 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.15% | $10,745,662 | $214.91 | -50,000 | 2,277,843 | 15 Jun 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.1% | $10,701,645 | $214.03 | -50,000 | 2,327,843 | 12 Jun 2026 | Direct |
| Gail Boxer Marcus | NTRA | Common Stock | Sale | -64% | $2,389,328 | $217.21 | -11,000 | 6,183 | 05 Jun 2026 | Direct |
| Gail Boxer Marcus | NTRA | Common Stock | Options Exercise | 177.9% | 11,000 | 17,183 | 05 Jun 2026 | Direct | ||
| Gail Boxer Marcus | NTRA | Stock Option (right to buy) | Options Exercise | -50% | -11,000 | 11,000 | 05 Jun 2026 | Direct | ||
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -27.4% | $9,089,776 | $221.03 | -41,124 | 108,743 | 04 Jun 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -2.13% | $655,295 | $218.43 | -3,000 | 137,643 | 01 Jun 2026 | Direct |
| Roelof F. Botha | NTRA | Common Stock | Sale | -6.76% | $17,184,092 | $220.31 | -78,000 | 1,076,198 | 01 Jun 2026 | Estate planning vehicles |
| Eric H. Rubin | NTRA | Common Stock | Award | 42480% | 2,124 | 2,129 | 29 May 2026 | Direct | ||
| Solomon Moshkevich | NTRA | Common Stock | Sale | -1.16% | $335,091 | $202.84 | -1,652 | 140,643 | 26 May 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.77% | $291,684 | $202.84 | -1,438 | 185,782 | 26 May 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.7% | $151,169 | $201.56 | -750 | 19,532 | 13 May 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.7% | $151,177 | $201.57 | -750 | 19,532 | 13 May 2026 | By Caraluna 1 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.23% | $657,104 | $208.60 | -3,150 | 252,502 | 08 May 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Award | 0.1% | 2,389 | 2,378,791 | 05 May 2026 | Direct |
* marks a reported price that did not pass the local price check.